Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
3 Dow Stocks You Can Confidently Buy Now and Hold Forever
05:21am, Sunday, 19'th Feb 2023
These highly profitable, time-tested companies can make their shareholders significantly richer over time.
Should Income Investors Buy This Dow Jones Stock?
09:15am, Friday, 17'th Feb 2023
This drugmaker boasts an impressive product portfolio and pipeline.
Will Johnson & Johnson Remain A Top Dividend Aristocrat Stock Going Forward?
07:50am, Friday, 17'th Feb 2023
At the end of 2023, Johnson & Johnson will be spinning off its Consumer Health segment. Consumer Health has been the backbone of the company, but the Pharmaceutical and MedTech segments have provided
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
5 Stocks In The Dividend Growth Sweet Spot
04:08pm, Wednesday, 15'th Feb 2023
Finding companies with a high initial yield and rapid dividend growth is difficult. I present my criteria for finding such companies. At present, there are 16 companies meeting my initial screening re
Johnson & Johnson (JNJ) Presents at SVB Securities Global Biopharma Conference (Transcript)
04:08pm, Wednesday, 15'th Feb 2023
Johnson & Johnson (NYSE:JNJ ) SVB Securities Global Biopharma Conference February 15, 2023 1:00 PM ET Company Participants Biljana Naumovic - Worldwide President, Global Oncology Peter Lebowitz - Glob
Worried About 2023? Park Your Money in These 2 Low-Volatility Dividend Stocks
05:25am, Wednesday, 15'th Feb 2023
These stocks are low-risk investments with dividends yielding more than 2%.
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
08:42am, Tuesday, 14'th Feb 2023
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global HealthCare Conference on Tuesday, March 14th, at the Loews Miami Beach Hotel, Miami Beach, F
Better Buy: Johnson & Johnson or AbbVie?
08:26am, Tuesday, 14'th Feb 2023
The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead.
4 Stock Market Sweethearts You'll Want to Call Your Own
05:05am, Tuesday, 14'th Feb 2023
It's easy to fall in love with game-changing businesses.
What Stocks To Buy Today? 2 Defensive Stocks To Know
10:16am, Monday, 13'th Feb 2023
Do you have these defensive stocks on your radar right now?
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
05:33am, Monday, 13'th Feb 2023
Income stocks can lend portfolio growth in both up and down markets.
How This Income Method Could Lead To Financial Freedom
09:00am, Saturday, 11'th Feb 2023
We will go over our thesis as to how a diversified income method with low volatility could make you financially independent. We regularly write about multi-basket income strategies with an in-built he
3 of the Best Dividend Stocks to Buy for February
01:19pm, Friday, 10'th Feb 2023
The stock market has had a blistering start to 2023, erasing some fears that prevailed during the 2022 bear market, when dividend stocks were very popular. But we're not out of the woods quite yet, so
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
12:48pm, Friday, 10'th Feb 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
